SB 1580 — Modifies provisions relating to ketamine
Last action — Second Read and Referred S Families, Seniors and Health Committee
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill is in committee in the Senate. Introduced January 20, 2026. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the Senate.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
-
In Committee
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Summary
SB 1580 - This act creates a new provision relating to the ordering and administering of ketamine for mental health purposes. The act provides that a licensed physician shall not delegate to any individual the authority to order ketamine hydrochloride for mental health purposes. Further, any licensed physician who delegates the administration of ketamine to a certified registered nurse anesthetist shall be on site and immediately available to supervise and respond during such treatment. Intravenous ketamine hydrochloride treatment for mental health purposes shall not be administered without a documented diagnosis and treatment plan from a physician. This act is identical to SB 830 (2025) and substantially similar to HB 1043 (2025). SARAH HASKINS
Bill Text
- Introduced 6781S.01I - Introduced Current pdf
Action History
-
Second Read and Referred S Families, Seniors and Health Committee
-
S First Read
Sponsors
- Jason Bean · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 198 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (198)
198 members have not signed on to this bill.
Show all 198 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 1580 do?
- SB 1580 - This act creates a new provision relating to the ordering and administering of ketamine for mental health purposes. The act provides that a licensed physician shall not delegate to any individual the authority to order ketamine hydrochloride for mental health purposes. Further, any licensed physician who delegates the administration of ketamine to a certified registered nurse anesthetist shall be on site and immediately available to supervise and respond during such treatment. Intravenous ketamine hydrochloride treatment for mental health purposes shall not be administered without a documented diagnosis and treatment plan from a physician. This act is identical to SB 830 (2025) and substantially similar to HB 1043 (2025). SARAH HASKINS
- Who sponsors SB 1580?
- SB 1580 is sponsored by Jason Bean.
- What is the current status of SB 1580?
- This bill is in committee in the Senate. Introduced January 20, 2026. It must pass committee before a floor vote.
- Where can I track SB 1580?
- Track SB 1580 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 1580
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 1580
Last checked for changes about 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →